“We are fortunate to live in a moment in history when modern medicine has truly changed the world. Today, genetics and data are driving new frontiers of drug innovation and creating a new view of disease. Biopharma, researchers, academia, governments, regulators and analysts are engaged together in a global effort to advance medicine and learning to play new roles as a result. This new healthcare reality requires meaningful collaboration to make a difference in public health.”
Dennis Gillings, CBE, Ph.D. Executive Chairman, Quintiles
Dr. Gillings was born and educated in the United Kingdom. He began providing statistical consulting and data management services to pharmaceutical clients in 1974 during his tenure as Professor of Biostatistics at the University of North Carolina at Chapel Hill. Dr. Gillings founded Quintiles in 1982, which grew out of his consulting activities with the pharma industry. He took Quintiles public on NASDAQ in 1994 and led its privatization in 2003. Today, Quintiles is the largest global provider of clinical trials and commercial marketing services to the pharma and biotechnology industry.
With more than 30 years of experience in drug development applications and theory, Dr. Gillings has provided expert consultation to numerous companies and health organizations, including the National Cancer Institute, the National Institute for Dental Research and the Institute of Medicine. He has served on several Advisory Boards and Councils including the Cambridge Judge Business School Advisory Board, the Scottish Enterprise Advisory Board and the International Advisory Council in Singapore. He also was the founding Chairman of the Association of Clinical Research Organizations, a Washington-based trade group formed in 2002.
He served for more than 15 years as a professor at the University of North Carolina at Chapel Hill and received the Honorary Degree of Doctor of Science in May 2001.
He was honored by the Queen as Commander of the Most Excellent Order of the British Empire in 2004 for services to the Pharmaceutical Industry. He was appointed Pro-Chancellor of Southampton University in 2006.
In June 2008, Dr. Gillings was made Honorary Fellow of Queen Mary, University of London and was awarded an Honorary DSc at the University of Southampton. In September, 2008, the School of Public Health at UNC Chapel Hill was named the Gillings School of Global Public Health. Its mission is to improve public health, promote individual well-being, and eliminate health disparities across North Carolina and around the world. In July, 2011, Dr. Gillings received an Honorary DSc at the University of Exeter.